- Entry
- $28.44
- Final
- $37.87 +33.2%
- Target
- —
- Score
- +1.00
Going all in, 80k @ $28.44/share. They hired former CCO of Eli Lilly about a month ago to potentially prepare for commercialization or buyout, assuming for their weight loss drug VK2735 (entering phase 3). If that isn’t a signal of intent idk what is. See you all @ Wendy’s
— ORIGINAL POST ·
Viking therapeutics (VKTX) moonshot
· r/wallstreetbets
· Feb 9, 2026